EU Regulatory Requirements Update, the latest news and developments. Hans-Heiner Junker TÜV SÜD Product Service GmbH October 2013

Size: px
Start display at page:

Download "EU Regulatory Requirements Update, the latest news and developments. Hans-Heiner Junker TÜV SÜD Product Service GmbH October 2013"

Transcription

1 EU Regulatory Requirements Update, the latest news and developments Hans-Heiner Junker TÜV SÜD Product Service GmbH October 2013 Folie 1

2 Content Two groups of Notified Bodies Designation process with European involvement More qualification requirements for auditors, experts and certification personnel Reprocessing not possible, but Qualified person Implant Card Folie 2

3 2 Different Groups of Notified Bodies Group 1: Notified Body for class I, II a and II b Group 2: Notified Body for high-risk devices Group 1 will be designated by national authorities Supervision by national authorities, plus other national authorities, plus European agency Group 2 will be designated by EMA Supervision by national authorities, plus other national authorities, plus European agency, plus EMA Group 2 will include the Notified Bodies called :Special Notified Bodies Folie 3

4 No PMA, but Article 43a Involvement of the Special notified bodies in the conformity assessment procedures of high-risk devices Only Special notified bodies (SNB) shall be entitled to conduct conformity assessments for the following devices: implantable devices, devices referred to in Article 1(4), devices referred to in Article 1(5) and point 5.3. of Annex VII (Rule 11), devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non-viable or are rendered non-viable, or Class III devices. Folie 4

5 High-Risk Devices devices referred to in Article 1(4) states: Where a device, when placed on the market or used in accordance with the manufacturer's instructions, incorporates, as an integral part, a substance which, if used separately, would be considered to be a medicinal product as defined in Article 1(2) of Directive 2001/83/EC, including a medicinal product derived from human blood or human plasma as defined in Article 1(10) of that Directive, with action ancillary to that of the device, that device shall be assessed and authorised in accordance with this Regulation. Folie 5

6 High-Risk Devices devices referred to in Article 1(5) and point 5.3. of Annex VII (Rule 11) Article 1(5) states: Where a device is intended to administer a medicinal product as defined in Article 1(2) of Directive 2001/83/EC, that device shall be governed by this Regulation, without prejudice to the provisions of Directive 2001/83/EC with regard to the medicinal product. Rule 11 states: All active devices intended to administer and/or remove medicines, body liquids or other substances to or from the body are in class IIa, unless this is done in a manner that is potentially hazardous, taking account of the nature of the substances involved, of the part of the body concerned and if the mode of application in which case they are in class II b. Folie 6

7 Electronic system on "Special notified bodies The Commission, in collaboration with the Agency, shall establish and regularly update an electronic registration system for: the registration of applications and granted authorisations to perform conformity assessments as Special notified bodies under this Section and to collate and process information on the name of the Special notified bodies; the exchange of information with national authorities; and for the publication of assessment reports; The information collated and processed in the electronic system and which relates to Special notified bodies shall be accessible to the public. Folie 7

8 Article 44: Mechanism for scrutiny of certain conformity assessments Deleted, but... Article 44 a (new):assessment procedure for the conformity assessments of certain high-risk devices Applications from manufacturer must be forwarded to EMA and Commission by the SNB Draft instructions for use Draft summary of safety and clinical performance report Estimated date of completion Commission will forward this information to ACMD (21 sub-groups) Folie 8

9 Article 44 a (new): Within 20 days of receipt of the information referred to in paragraph 1, the ACMD may decide... The members of the relevant sub-group of the ACMD shall decide... The ACMD shall issue an opinion on the summary of the preliminary conformity assessment at the latest 60 days after its submission... The ACMD shall inform the Commission, the notified body and the manufacturer of its opinion within 5 days of its adoption... More involvement = more time = more time to market More involvement = more resources = more money Folie 9

10 ACMD Article 78 a (new): Assessment Committee for Medical Devices The ACMD shall be composed of sub-groups, in accordance with the medical fields referred to in paragraph 3... Each sub-group of the ACMD shall be composed of: One expert from member states Where available: three representatives of patients' organisations... One representative of the European Medicines Agency (EMA) All for a three-year term which may be renewed Folie 10

11 Following sub-groups will be established: 1. Anaesthesiology 2. Blood grouping or tissue typing 3. Blood transfusion and transplantation 4. Cardiology 5. Communicable diseases 6. Dentistry 7. Dermatology 8. Ear / Nose / Throat (ENT) 9. Endocrinology 10. Gastroenterology 11. General/Plastic surgery 12. Medical genetics 13. Nephrology / Urology 14. Neurology 15. Obstetrics/Gynaecology 16. Oncology 17. Ophthalmology 18. Orthopaedics 19. Physical medicine 20. Pulmonology / Pneumology 21. Radiology Folie 11

12 Designation Process for Group 1... a joint assessment team made up of at least three experts chosen from a list of experts who are qualified in the assessment of conformity assessment bodies and free of conflicts of interest with the applicant conformity assessment body. The list shall be drawn up by the Commission in cooperation with the MDCG. At least one of these experts shall be a representative of the Commission, and at least one other shall come from a Member State other than the one in which the applicant conformity assessment body is established. The Commission representative shall lead the joint assessment team....the relevant national authority shall base its decision on the designation of the notified body on the recommendation by the MDCG. In case where its decision differs from the MDCG recommendation, the relevant national authority shall provide the MDCG in writing with all the necessary justification for its decision... Folie 12

13 Classification In order to ensure consistent classification across all Member States, particularly with regards to borderline cases, it should be the responsibility of the Commission, having consulted the MDCG and the MDAC, to decide on a case-by-case basis whether or not a product or groups of products fall within the scope of this Regulation. Member States should also have the possibility to request the Commission to take a decision on the appropriate regulatory status of a product, or category or group of products. MDCG defined in Article 78 Folie 13

14 Article 78a (new): Medical Device Advisory Committee The Commission shall establish a multidisciplinary Medical Device Advisory Committee (MDAC) composed of experts and representatives of the relevant stakeholders in order to provide support, advice and expertise to the MDCG, the Commission and Member States on technical, scientific, social and economic aspects of regulating medical devices and in vitro diagnostic medical devices, such as in the field of medical technology, borderline cases involving medicinal products, human tissues and cells, cosmetics, biocides, food and, if necessary, other products, as well as further aspects of the implementation of this Regulation. Folie 14

15 Groups Involved EMA = European Medicines Agency MDCG = Medical Device Coordination Group MDAC = Medical Device Advisory Committee ACMD = Assessment Committee for Medical Devices Notified Bodies Special Notified Bodies Joint audits by national designating authorities designating authorities from other member states Representative of the European Commission Independent body for the review of manufacturer's PMCF evaluation report Folie 15

16 Reprocessing of single use devices Article 15a General principles on single-use devices and reprocessing of reusable devices All medical devices shall be treated as reusable devices unless: they are listed as single-use devices unsuitable for reprocessing referred to in Article 15 b, or they are labelled as 'single-use' by the manufacturer, in accordance with Article 15 c. Folie 16

17 Article 15 b List of single-use devices unsuitable for reprocessing In accordance with Article 15 a (1) first indent, the Commission, by means of delegated acts, shall establish and regularly update, including by adding or removing, a list of medical devices which are unsuitable for reprocessing. These devices shall be labelled as single-use, owing in particular to their intended use in or on the human body and the body parts they will be in contact with, the conditions of their use, their intended purpose and the material of which they are composed of. Folie 17

18 Article 15 c Labelling of medical devices as "single-use" Where a device is labelled as "single-use", in accordance with Article 15 a (1), second indent, it is the responsibility of the manufacturer to provide a justification based on sufficient scientific evidence, such as tests results or reference to relevant standards, studies and recent scientific publications in the field of reprocessing, that the device cannot be reprocessed safely. Folie 18

19 Article 15 d Requalification of a single-use device as reusable Any natural or legal person who wishes to reprocess a device labelled as "single-use" included in the special list of single-use devices, in accordance with Article 15 b, or in accordance with Article 15 c, and who has evidence that such a device could be safely reprocessed shall inform the Commission of the intention to do so. The requisite evidence shall be submitted by the natural or legal person who wishes to reprocess a device to one of the EU reference laboratories, as referred to in Article 81. Folie 19

20 Article 15 e Reprocessing of medical devices labelled as reusable Any natural or legal person, including health institutions as specified in Article 4(4), who reprocesses a device labelled as "reusable" shall: comply with the EU standards referred to in paragraph 2; ensure that, in case of a single-use device re-qualified as reusable in accordance with the procedure referred to in Article 15 (d), the reusable device is reprocessed in accordance with the opinion of the EU reference laboratory, as referred to in Article 15 (d), paragraph 2; ensure that the reusable device is not reprocessed beyond the maximum number of times specified for that device; be held responsible for its reprocessing activities. Folie 20

21 Definition Old definition of single-use device has been deleted instead 'single-use device' means a device that is intended to be used on an individual patient during a single procedure and which has been tested and demonstrated to be impossible to reuse. "Reusable device" means a device that is intended to be used on multiple patients or during multiple procedures. Folie 21

22 Qualified Person Draft: Manufacturers shall have available within their organisation at least one qualified person who possesses expert knowledge in the field of medical devices Compromise: Manufacturers shall have available within their organisation at least one person responsible for regulatory compliance who possesses the requisite expertise in the field of medical devices Expertise for specific devices? Folie 22

23 Implant Card This card shall contain the following: the information allowing identification of the device, including the Unique Device Identification any warnings, precautions or measures to be taken by the patient or a healthcare professional with regard to reciprocal interference with reasonably foreseeable external influences or environmental conditions description of potential adverse effects any information about the expected lifetime of the device and any necessary follow-up principal characteristics of the device, including the materials used Member States may introduce national provisions requiring that the implant card includes also information on post-operative follow-up care measures The following implants shall be exempted from this obligation: sutures, staples, dentals implants, screws and plates. Folie 23

24 Transparency Eudamed shall include the following as integral parts: 1.the electronic system on UDI referred to in Article 24; 2.the electronic system on registration of devices and economic operators referred to in Article 25; 3.the electronic system on information on certificates referred to in Article 45(4); 4.the electronic system on clinical investigations referred to in Article 53, 5.the electronic system on vigilance referred to in Article 62; 6.the electronic system on market surveillance referred to in Article the electronic system on registration of subsidiaries and subcontracting referred to in Article 29a. Folie 24

25 Still included Annex I: Essential Requirements on the Safety and Performance Annex II: Technical Documentation Annex XV: Devices as medical devices Transition period: 3 years New application of organizations that would like to become a Notified Body Folie 25

26 What Jungle? Commission Council European Parliament Folie 26

27 Estimated Output New MDR Trilogy Folie 27

28 Thanks for your patience Folie 28

KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE

KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE RNI Conseil 2017 Tous droits réservés Toute reproduction interdite sans l'autorisation de l'auteur. KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE Anne Laure TARDY, PhD

More information

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES COMPETENT AUTHORITY (UK) 10 EC MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES (CUSTOM MADE DEVICES) Updated March 2008 CONTENTS PAGE Introduction 3 Definition of dental

More information

DIRECTIVES. (Text with EEA relevance)

DIRECTIVES. (Text with EEA relevance) L 238/44 DIRECTIVES COMMISSION DIRECTIVE (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of

More information

(Legislative acts) REGULATIONS

(Legislative acts) REGULATIONS 31.12.2010 Official Journal of the European Union L 348/1 I (Legislative acts) REGULATIONS REGULATION (EU) No 1235/2010 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards

More information

Working Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT

Working Document prepared by the Commission services - does not prejudice the Commission's final decision 3/2/2014 COMMISSION STAFF WORKING DOCUMENT COMMISSION STAFF WORKING DOCUMENT on certain requirements for FSMPs [Supporting Document for the Expert Group meeting of 7 February 2014] Introduction Following the discussions in the Expert Group meeting

More information

EUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621

EUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621 EUROPEAN UNION THE EUROPEAN PARLIAMT Brussels, 15 October 2007 (OR. en) THE COUNCIL 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Regulation

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 2007R1394 EN 02.07.2012 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 1394/2007 OF THE EUROPEAN

More information

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, European Medicines Agency PHARM 689 PHARMACEUTICAL COMMITTEE 21 October 2015

More information

REGULATION (EC) No.141/2000

REGULATION (EC) No.141/2000 REGULATION (EC) No.141/2000 Community legislation in force Document 300R0141 Directory chapters where this document can be found: [15.30 Health promotion] Regulation (EC) No.141/2000 of the European Parliament

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10.12.2008 COM(2008) 664 final 2008/0257 (COD) Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending, as regards pharmacovigilance

More information

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893 COUNCIL OF THE EUROPEAN UNION Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DLEG 51 CODEC 893 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Common Position with

More information

COMMISSION DELEGATED REGULATION (EU).../... of XXX

COMMISSION DELEGATED REGULATION (EU).../... of XXX EUROPEAN COMMISSION Brussels, XXX SANTE/10355/2015 (POOL/E4/2015/10355/10355-EN. doc) [...1(2015) XXX draft COMMISSION DELEGATED REGULATION (EU).../... of XXX supplementmg Regulation (EU) No 609/2013 of

More information

Secretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director

Secretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director COUNCIL OF THE EUROPEAN UNION Brussels, 13 February 2014 (OR. en) 6438/14 COVER NOTE From: date of receipt: 3 February 2014 To: No. Cion doc.: PHARM 14 SAN 72 MI 161 COMPET 107 DELACT 29 Secretary-General

More information

COMMISSION IMPLEMENTING DECISION. of

COMMISSION IMPLEMENTING DECISION. of EUROPEAN COMMISSION Brussels, 4.7.2017 C(2017) 4462 final COMMISSION IMPLEMENTING DECISION of 4.7.2017 on the identification of bis(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), benzyl butyl

More information

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL EUROPEAN COMMISSION Brussels, 22.8.2017 COM(2017) 438 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the exercise of the delegation conferred on the Commission pursuant

More information

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004 30.4.2004 Official Journal of the European Union L 136/85 DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products,

More information

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014) AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred

More information

COMMISSION REGULATION (EU)

COMMISSION REGULATION (EU) 11.3.2011 Official Journal of the European Union L 64/15 COMMISSION REGULATION (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 1997R0258 EN 07.08.2009 004.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B REGULATION (EC) No 258/97 OF THE EUROPEAN PARLIAMENT

More information

Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human medicinal products

Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human medicinal products 25 June 2013 rev. 1 1. Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human 1 Editorial revisions have been made to the table of

More information

Wyss Zürich Regulatory Affairs Seminar

Wyss Zürich Regulatory Affairs Seminar Wyss Zürich Regulatory Affairs Seminar Hospital Exemption & Compassionate Use EU Framework Catherine Longeval Koen T Syen Zürich, 5 July 2017 1 Table of contents Introduction Hospital Exemption Implementation

More information

Medical Devices Act 1

Medical Devices Act 1 Issuer: Riigikogu Type: act In force from: 01.01.2016 In force until: 31.05.2016 Translation published: 01.02.2016 Medical Devices Act 1 Amended by the following acts Passed 13.10.2004 RT I 2004, 75, 520

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices

This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices agencia española de medicamentos y productos sanitarios This is an unofficial English translation of the Royal Decree 1344/2007 revised by the Spanish Agency for Medicines and Medical Devices ROYAL DECREE

More information

EUR-Lex L EN. Council Directive 93/74/EEC of 13 September 1993 on feedingstuffs intended for particular nutritional purposes

EUR-Lex L EN. Council Directive 93/74/EEC of 13 September 1993 on feedingstuffs intended for particular nutritional purposes Page 1 of 5 Avis juridique important 31993L0074 Council Directive 93/74/EEC of 13 September 1993 on feedingstuffs intended for particular nutritional purposes Official Journal L 237, 22/09/1993 P. 0023-0027

More information

C 178/2 Official Journal of the European Union

C 178/2 Official Journal of the European Union C 178/2 Official Journal of the European Union 29.7.2003 Communication from the Commission on Regulation (EC) No 141/2000 of the European Parliament and of the Council on orphan medicinal products (2003/C

More information

Guidelines to Commission Regulation (EU) No 655/2013. laying down common criteria for the justification of claims used

Guidelines to Commission Regulation (EU) No 655/2013. laying down common criteria for the justification of claims used Ref. Ares(2015)5892153-16/12/2015 Version July 2013 Guidelines to Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products

More information

CHAPTER 3. Union Referral Procedures MAY 2014

CHAPTER 3. Union Referral Procedures MAY 2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products Brussels, Revision May 2014 NOTICE TO APPLICANTS VOLUME 2A Procedures for marketing authorisation

More information

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 5.12.2008 COM(2008) 824 final REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT on the use of substances other than vitamins

More information

The Nutrition (Amendment) (EU Exit) Regulations 2018

The Nutrition (Amendment) (EU Exit) Regulations 2018 The Nutrition (Amendment) (EU Exit) Regulations 2018 A public consultation Contents Introduction... 3 Why we are consulting... 4 Nutrition and Health Claims... 6 Proposals... 6 Vitamins, minerals, and

More information

Annex II - List of enforceable provisions of REACH and CLP

Annex II - List of enforceable provisions of REACH and CLP Annex II - List of enforceable provisions of REACH and CLP The provisions below are listed according to the sections of the main report, together with the Titles of the Regulation in the case of REACH.

More information

CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS

CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS CED GUIDELINES TO INTERPRET AND IMPLEMENT COUNCIL DIRECTIVE 2011/84/EU ON TOOTH WHITENING PRODUCTS I INTRODUCTION This document provides guidance for interpreting and implementing the Council Directive

More information

MOTION FOR A RESOLUTION

MOTION FOR A RESOLUTION EUROPEAN PARLIAMT 2009-2014 Plenary sitting 07.3.2012 B7-0000/2012 MOTION FOR A RESOLUTION further to Question for Oral Answer B7-0000/2012 pursuant to Rule 115(5) of the Rules of Procedure on Defective

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency London, 26 July 2006 Doc. Ref. EMEA/186279/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON LEGAL STATUS FOR THE SUPPLY TO THE PATIENT OF CENTRALLY AUTHORISED

More information

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes

Standard Operating Procedure. Selection of studies performed in compliance with Good Laboratory Practice for audit purposes Scope To describe the procedure for EFSA to request on a yearly or ad-hoc basis the performance of GLP studies audits by the GLP Monitoring Authorities. To lay down criteria for the selection of the GLP

More information

PGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne

PGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne Public consultation on Delegated Act on Post-Authorisation efficacy studies PGEU RESPONSE INTRODUCTION The Pharmaceutical Group of the European Union (PGEU) is the association representing community pharmacists

More information

Holders of European Union marketing authorizations

Holders of European Union marketing authorizations PRAC Experience The legal framework The Pharmacovigilance legislation (Regulation No 1235/2010 and Directive 2010/84/EU) was adopted by the European Parliament and European Council in December 2010. The

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) The European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 15 December 2005 EMEA/357981/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON PROCEDURES

More information

QA Regulatory forum: Classification and Risk assessment according to MDR Date : T h e r e s e. A l b i n s s o m e d q t e c h.

QA Regulatory forum: Classification and Risk assessment according to MDR Date : T h e r e s e. A l b i n s s o m e d q t e c h. QA Regulatory forum: Classification and Risk assessment according to MDR Date : 05.04.2018 THERESE ALBINSSON T h e r e s e. A l b i n s s o n @ m e d q t e c h. s e MedQtech AB MedQtech AB is a consultant

More information

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL sante.ddg2.g.dir(2015)2952292 SUMMARY REPORT OF THE STANDING COMMITTEE ON PLANTS, ANIMALS, FOOD AND FEED HELD IN BRUSSELS ON 09 JUNE 2015

More information

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz Collaboration Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz Nutritional Risk Management Area of the Subdirectorate-General for Food Safety Promotion Spanish

More information

European Stability Mechanism Guideline on Precautionary Financial Assistance

European Stability Mechanism Guideline on Precautionary Financial Assistance European Stability Mechanism Guideline on Precautionary Financial Assistance Article 1 Aim and scope The objective of precautionary financial assistance is to support sound policies and prevent crisis

More information

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP

CONSTITUTION ARTICLE I NAME AND LOGO ARTICLE II OBJECTIVES AND PURPOSES ARTICLE III MEMBERSHIP ARTICLE I NAME AND LOGO CONSTITUTION The name of the Society is Cameroon Radiological Protection Society which is created in 28 th September 2012 may be referred to in abbreviated form as CRPS. The logo

More information

Procedure. Identify all possible radiation hazards.

Procedure. Identify all possible radiation hazards. Guidance Notes on Radiation Risk Assessment Prior to commencing any new work practice involving a source of ionising radiation it is important that a realistic assessment of the radiation risks is carried

More information

CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS

CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of

More information

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014 Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014 Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role

More information

CHAPTER 3. September 2007

CHAPTER 3. September 2007 EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, ENTR/F2/SM D(2007) Revision September 2007 NOTICE TO APPLICANTS VOLUME 2A Procedures for marketing

More information

VOLUME 6A Procedures for marketing authorisation

VOLUME 6A Procedures for marketing authorisation EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 27.09.2007 ENTR/F2/KK D(2007) Revision September 2007 NOTICE TO APPLICANTS VETERINARY MEDICINAL

More information

Access to electronic communications services for disabled customers

Access to electronic communications services for disabled customers Access to electronic communications services for disabled customers Statement Publication date: 12 March 2014 Contents Section Page 1 Summary 1 2 Introduction 2 3 Access to and pricing of the relay service

More information

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC) L 327/34 COUNCIL RECOMMDATION of 2 December 2003 on cancer screening (2003/878/EC) THE COUNCIL OF THE EUROPEAN UNION, Having regard to the Treaty establishing the European Community, and in particular

More information

Guideline on the processing of renewals in the centralised procedure

Guideline on the processing of renewals in the centralised procedure 14 July 2016 Committee for Human Medicinal Products (CHMP) Guideline on the processing of renewals in the centralised procedure Transmission to CPMP November 2000 Release for consultation December 2000

More information

Delegations will find attached document D048379/05.

Delegations will find attached document D048379/05. Council of the European Union Brussels, 17 August 2017 (OR. en) 11651/17 AGRILEG 150 DENLEG 63 COVER NOTE From: European Commission date of receipt: 24 July 2017 To: No. Cion doc.: D048379/05 Subject:

More information

Introduction. Doc-Biocides-2002/01 Version

Introduction. Doc-Biocides-2002/01 Version Doc-Biocides-2002/01 Version 08.01.2008 Guidance document agreed between the Commission services and the competent authorities of the Member States for the Biocidal Products Directive 98/8/EC and for the

More information

Assurance Engagements Other than Audits or Review of Historical Financial Statements

Assurance Engagements Other than Audits or Review of Historical Financial Statements Issued December 2007 International Standard on Assurance Engagements Assurance Engagements Other than Audits or Review of Historical Financial Statements The Malaysian Institute Of Certified Public Accountants

More information

INTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION CONTENTS

INTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION CONTENTS INTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION (Effective for assurance reports dated on or after January 1,

More information

COMMISSION DELEGATED REGULATION (EU) /... of XXX

COMMISSION DELEGATED REGULATION (EU) /... of XXX EUROPEAN COMMISSION Brussels, XXX SANTE/11481/2018 CIS (POOL/E1/2018/11481/11481-EN CIS.doc) [ ](2018) XXX draft COMMISSION DELEGATED REGULATION (EU) /... of XXX amending Commission Delegated Regulation

More information

on the advertising of medicinal products for human use

on the advertising of medicinal products for human use 30. 4. 92 Official Journal of the European Communities No L 113 / 13 COUNCIL DIRECTIVE 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use THE COUNCIL OF THE EUROPEAN COMMUNITIES,

More information

DIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

DIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL L 174/74 Official Journal of the European Union 1.7.2011 DIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to

More information

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 23 APRIL 2014

EUROPEAN COMMISSION SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 23 APRIL 2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Brussels, SANCO G ARES(2014)1527282 SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH Chairmen : HELD IN BRUSSELS

More information

ISO INTERNATIONAL STANDARD. Non-destructive testing Qualification of personnel for limited applications of non-destructive testing

ISO INTERNATIONAL STANDARD. Non-destructive testing Qualification of personnel for limited applications of non-destructive testing INTERNATIONAL STANDARD ISO 20807 First edition 2004-03-01 Non-destructive testing Qualification of personnel for limited applications of non-destructive testing Essais non destructifs Qualification du

More information

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents 1989L0107 EN 10.09.1994 001.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE of 21December 1988 on the approximation

More information

IMPORTANT DISCLAIMER. Note

IMPORTANT DISCLAIMER. Note yn EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL June 2012 DRAFT GUIDANCE DOCUMENT FOR COMPETENT AUTHORITIES FOR THE CONTROL OF COMPLIANCE WITH EU LEGISLATION ON: Regulation (EU) No 1169/2011

More information

on the approximation of the laws of the Member States concerning food additives authorized for use in foodstuffs intended for human consumption

on the approximation of the laws of the Member States concerning food additives authorized for use in foodstuffs intended for human consumption 11. 2. 89 Official Journal of the European Communities No L 40/ 27 COUNCIL DIRECTIVE of 21 December 1988 on the approximation of the laws of the Member States concerning food additives authorized for use

More information

EUROPEAN UNION. Brussels, 29 June 2010 (OR. en) 2008/0238 (COD) PE-CONS 19/1/10 REV 1 SAN 114 CODEC 431

EUROPEAN UNION. Brussels, 29 June 2010 (OR. en) 2008/0238 (COD) PE-CONS 19/1/10 REV 1 SAN 114 CODEC 431 EUROPEAN UNION THE EUROPEAN PARLIAMT THE COUNCIL Brussels, 29 June 2010 (OR. en) 2008/0238 (COD) PE-CONS 19/1/10 REV 1 SAN 114 CODEC 431 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: DIRECTIVE OF THE EUROPEAN

More information

REACH Authorisation. REACH Conference Bratislava September 3-4, 2018

REACH Authorisation. REACH Conference Bratislava September 3-4, 2018 REACH Conference Bratislava September 3-4, 2018 REACH Authorisation Martin Murín, MSc. Ekotox Centers Ekotoxikologické centrum Bratislava s.r.o. Tomášikova 10/F, 821 03 Bratislava Tel/Fax.: +421 45943712

More information

(Text with EEA relevance) Having regard to the opinion of the European Economic and Social Committee ( 1 ),

(Text with EEA relevance) Having regard to the opinion of the European Economic and Social Committee ( 1 ), 27.12.2017 Official Journal of the European Union L 345/87 DIRECTIVE (EU) 2017/2398 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 12 December 2017 amending Directive 2004/37/EC on the protection of

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10.12.2008 COM(2008) 663 final 2008/0256 (COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending, as regards information

More information

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 30 April 2012 EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 30 April 2012 Chairmen: Mr Basil

More information

Official Journal of the European Union REGULATIONS

Official Journal of the European Union REGULATIONS L 259/2 REGULATIONS COMMISSION DELEGATED REGULATION (EU) 2017/1798 of 2 June 2017 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional

More information

COMMISSION DELEGATED REGULATION (EU) /... of XXX

COMMISSION DELEGATED REGULATION (EU) /... of XXX EUROPEAN COMMISSION Brussels, XXX SANTE/11481/2018 CIS (POOL/E1/2018/11481/11481- CIS.doc) [ ](2018) XXX draft COMMISSION DELEGATED REGULATION (EU) /... of XXX amending Commission Delegated Regulation

More information

SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law)

SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section General Food Law) EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Brussels, SANCO E 1718316 SUMMARY REPORT OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 10 DECEMBER 2012 (Section

More information

DRAFT COMMISSION DELEGATED REGULATION (EU) /... of XXX

DRAFT COMMISSION DELEGATED REGULATION (EU) /... of XXX EUROPEAN COMMISSION Brussels, XXX C(2016) 3752 projet DRAFT COMMISSION DELEGATED REGULATION (EU) /... of XXX setting out scientific criteria for the determination of endocrine-disrupting properties pursuant

More information

L A W ON RADIATION PROTECTION OF THE REPUBLIC OF LITHUANIA

L A W ON RADIATION PROTECTION OF THE REPUBLIC OF LITHUANIA Translation from Lithuanian Law published in the official gazette Valstybės žinios, 1999, No. 11-239 The wording of the Law comes into force on 01-10-2011 The wording of sub-paragraph 2 of paragraph 3

More information

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below. ADVISORY Food & Drug FDA ISSUES PROPOSED RULE TO ESTABLISH A UNIQUE DEVICE IDENTIFICATION SYSTEM FOR MEDICAL DEVICES July 16, 2012 On July 11, 2012, the Food and Drug Administration (FDA) published in

More information

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food EUROPEAN COMMISSION Brussels, XXX SANTE/11059/2016 Rev. 2 (POOL/E2/2016/11059/11059R2- EN.doc) D048379/05 [ ](2017) XXX draft COMMISSION REGULATION (EU) / of XXX establishing mitigation measures and benchmark

More information

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food

COMMISSION REGULATION (EU) / of XXX. establishing mitigation measures and benchmark levels for the reduction of the presence of acrylamide in food EUROPEAN COMMISSION Brussels, XXX SANTE/11059/2016 Rev. 2 (POOL/E2/2016/11059/11059R2- EN.doc) D048379/05 [ ](2017) XXX draft COMMISSION REGULATION (EU) / of XXX establishing mitigation measures and benchmark

More information

COMMISSION REGULATION (EU) / of XXX. authorising certain health claims made on foods and referring to children's development and health

COMMISSION REGULATION (EU) / of XXX. authorising certain health claims made on foods and referring to children's development and health EUROPEAN COMMISSION Brussels, XXX SANTE/10891/2015 [ ](2015) XXX draft COMMISSION REGULATION (EU) / of XXX authorising certain health claims made on foods and referring to children's development and health

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 8.12.2008 COM(2008) 818 final 2008/0238 (COD) Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on standards of quality and safety

More information

Specialist List in Special Care Dentistry

Specialist List in Special Care Dentistry Specialist List in Special Care Dentistry Definition of Special Care Dentistry Special Care Dentistry (SCD) is concerned with providing enabling the delivery of oral care for people with an impairment

More information

Reports of Cases OPINION OF ADVOCATE GENERAL SHARPSTON 1. delivered on 30 May Laboratoires Lyocentre

Reports of Cases OPINION OF ADVOCATE GENERAL SHARPSTON 1. delivered on 30 May Laboratoires Lyocentre Reports of Cases OPINION OF ADVOCATE GENERAL SHARPSTON 1 delivered on 30 May 2013 Case C-109/12 Laboratoires Lyocentre (Request for a preliminary ruling from the Korkein hallinto-oikeus (Finland)) (Medicinal

More information

Code of Practice for Radiation Protection in Dentistry. Code of Practice For Radiation Protection in Dentistry

Code of Practice for Radiation Protection in Dentistry. Code of Practice For Radiation Protection in Dentistry Code of Practice for Radiation Protection in Dentistry Code of Practice For Radiation Protection in Dentistry 10 OCTOBER 2017 CONTENTS 1. INTRODUCTION... 3 1.0 CITATION... 3 1.1 BACKGROUND... 3 1.2 PURPOSE

More information

Proposed Radiation Safety Regulations: Submission form

Proposed Radiation Safety Regulations: Submission form Proposed Radiation Safety Regulations: Submission form Making a submission This form is designed to assist submitters responding to the discussion points in Proposed Radiation Safety Regulations: A consultation

More information

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 15 July 2009

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW. Summary Record of Meeting of 15 July 2009 EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 15 July 2009 Chairman: Mr Basil

More information

This document is meant purely as documentation tool and the institutions do not assume any liability for its contents

This document is meant purely as documentation tool and the institutions do not assume any liability for its contents 1978L0142 EN 01.02.1978 000.001 1 This document is meant purely as documentation tool and the institutions do not assume any liability for its contents "B COUNCIL DIRECTIVE of 30 January 1978 on the approximation

More information

European Commission request to the European Food Safety Authority for scientific advice on:

European Commission request to the European Food Safety Authority for scientific advice on: European Commission request to the European Food Safety Authority for scientific advice on: the Community list of permitted health claims pursuant article 13 of Regulation 1924/2006 on nutrition and health

More information

European Paediatric Network Legal Basis

European Paediatric Network Legal Basis Enpr-EMA Joint DIA/EFGCP/EMA Paediatric Forum 26 September 2011 Paolo Rossi Chairman Dept. of Pediatrics Tor Vergata University-Children s Hospital Bambino Gesù, Rome EnprEMA-PDCO Representative An agency

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE

More information

IMPLEMENTATION COURSE (MODULE 1) (ISO 45001:2016 AVAILABLE ON REQUEST) COURSE DURATION: 3 DAYS FOR OHSAS 18001:2007 OR ISO 45001:2016

IMPLEMENTATION COURSE (MODULE 1) (ISO 45001:2016 AVAILABLE ON REQUEST) COURSE DURATION: 3 DAYS FOR OHSAS 18001:2007 OR ISO 45001:2016 OHSAS 18001:2007 IMPLEMENTATION COURSE (MODULE 1) (ISO 45001:2016 AVAILABLE ON REQUEST) COURSE DURATION: 3 DAYS FOR OHSAS 18001:2007 OR ISO 45001:2016 Course Summary: The implementation course provides

More information

Falsified Medicines Directive - Safety Features Update

Falsified Medicines Directive - Safety Features Update Falsified Medicines Directive - Safety Features Update Catherine Neary GMP Conference 12 th November 2014 Agenda Background Delegated Act(s) Proposals Under Consideration White List & Black List Next Steps

More information

Market surveillance of medical devices

Market surveillance of medical devices Market surveillance of medical devices A joint action on market surveillance of medical devices to reinforce public health protection Information for healthcare professionals Introduction The European

More information

Class waiver list review

Class waiver list review Class waiver list review Background, approach and outcome Consequences for regulatory submissions EMA Industry stakeholder platform on Paediatric medicines Presented by Ralf Herold on 11 May 2015 Paediatric

More information

Ionising Radiation Policy

Ionising Radiation Policy Ionising Radiation Policy CONTENTS 1. University Policy. 2. Procedures / Guidance. 2.1 Responsibilities of the Deans of Schools and/or Heads of Departments 2.2 Radiation Protection Advisor / Radiation

More information

Memorandum of Understanding on the working relations between the European Commission and the European Stability Mechanism

Memorandum of Understanding on the working relations between the European Commission and the European Stability Mechanism Memorandum of Understanding on the working relations between the European Commission and the European Stability Mechanism 1- General objectives The European Commission (the Commission ) and the European

More information

Council of the European Union Brussels, 12 November 2015 (OR. en)

Council of the European Union Brussels, 12 November 2015 (OR. en) Council of the European Union Brussels, 12 November 2015 (OR. en) 14050/15 AGRILEG 222 DENLEG 147 VETER 102 COVER NOTE From: European Commission date of receipt: 12 November 2015 To: No. Cion doc.: D039258/04

More information

(Text with EEA relevance)

(Text with EEA relevance) L 204/36 EN COMMISSION IMPLEMENTING REGULATION (EU) 2018/1122 of 10 August 2018 authorising the placing on the market of pyrroloquinoline quinone disodium salt as a novel food under Regulation (EU) 2015/2283

More information

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:

More information

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION DECISION. of

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION DECISION. of COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 5.10.2009 C(2009)7726 COMMISSION DECISION of 5.10.2009 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and

More information

(Acts whose publication is obligatory) REGULATION (EC) No 726/2004 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

(Acts whose publication is obligatory) REGULATION (EC) No 726/2004 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004 30.4.2004 Official Journal of the European Union L 136/1 I (Acts whose publication is obligatory) REGULATION (EC) No 726/2004 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 laying down

More information

COMMISSION DELEGATED REGULATION (EU) /... of XXX

COMMISSION DELEGATED REGULATION (EU) /... of XXX EUROPEAN COMMISSION Brussels, XXX SANTE/11174/2016 (POOL/E1/2016/E1/11174/11174- EN.doc) [ ](2017) XXX draft COMMISSION DELEGATED REGULATION (EU) /... of XXX amending the Annex to Regulation (EU) No 609/2013

More information

October 2003 Revision 1, February INTRODUCTION AND SCOPE

October 2003 Revision 1, February INTRODUCTION AND SCOPE BEST PRACTICE GUIDE FOR THE EXCHANGE OF REGULATORY AND ADMINISTRATIVE INFORMATION REGARDING ORPHAN MEDICINAL PRODUCTS BETWEEN THE EMEA AND THE NATIONAL COMPETENT AUTHORITIES October 2003 Revision 1, February

More information